A Phase 1 Study of BMS-986453 in Participants with Relapsed and/or Refractory Multiple Myeloma
CA1190002
Phase 1 other active
Quick answer
A Phase 1 Study of BMS-986453 in Participants with Relapsed and/or Refractory Multiple Myeloma for Relapsed and/or Refractory Multiple Myeloma is a Phase 1 program (other) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Relapsed and/or Refractory Multiple Myeloma
- Phase
- Phase 1
- Modality
- other
- Status
- active